These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19073658)

  • 1. Risk factors for polyoma virus nephropathy.
    Prince O; Savic S; Dickenmann M; Steiger J; Bubendorf L; Mihatsch MJ
    Nephrol Dial Transplant; 2009 Mar; 24(3):1024-33. PubMed ID: 19073658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical course of polyoma virus nephropathy in 67 renal transplant patients.
    Ramos E; Drachenberg CB; Papadimitriou JC; Hamze O; Fink JC; Klassen DK; Drachenberg RC; Wiland A; Wali R; Cangro CB; Schweitzer E; Bartlett ST; Weir MR
    J Am Soc Nephrol; 2002 Aug; 13(8):2145-51. PubMed ID: 12138148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.
    El Ansary M; Abd Elhamid S; Saadi G; Ismail W; Ibrahim N; Bahaa El-Din N; Alhsyek S
    Transpl Infect Dis; 2016 Aug; 18(4):529-37. PubMed ID: 27226063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyomavirus nephropathy after renal transplantation: a single centre experience.
    Kim HC; Hwang EA; Han SY; Park SB; Park KK
    Nephrology (Carlton); 2005 Apr; 10(2):198-203. PubMed ID: 15877682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors and outcome in BK virus nephropathy in a Hispanic kidney transplant population.
    Pérez-Torres D; Bertrán-Pasarell J; Santiago-Delpín E; González-Ramos M; Medina-Mangual S; Morales-Otero L; González-Caraballo Z
    Transpl Infect Dis; 2010 Feb; 12(1):16-22. PubMed ID: 19804584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BK virus and SV40 co-infection in polyomavirus nephropathy.
    Li RM; Mannon RB; Kleiner D; Tsokos M; Bynum M; Kirk AD; Kopp JB
    Transplantation; 2002 Dec; 74(11):1497-504. PubMed ID: 12490781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
    Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
    Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periodic assessment of urine and serum by cytology and molecular biology as a diagnostic tool for BK virus nephropathy in renal transplant patients.
    Boldorini R; Brustia M; Veggiani C; Barco D; Andorno S; Monga G
    Acta Cytol; 2005; 49(3):235-43. PubMed ID: 15966283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic and clinical research in polyomavirus nephropathy.
    Trofe J; Gordon J; Roy-Chaudhury P; Koralnik I; Atwood W; Eash S; Alloway RR; Khalili K; Alexander JW; Woodle ES
    Exp Clin Transplant; 2004 Jun; 2(1):162-73. PubMed ID: 15859923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BK virus nephropathy in renal transplant patients in London.
    White LH; Casian A; Hilton R; Macphee IA; Marsh J; Sweny P; Trevitt R; Frankel AH; Warrens AN;
    Transplantation; 2008 Apr; 85(7):1008-15. PubMed ID: 18408582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine cytology as a screening method for polyoma virus active infection.
    Santos RL; Manfrinatto JA; Cia EM; Carvalho RB; Quadros KR; Alves-Filho G; Mazzali M
    Transplant Proc; 2004 May; 36(4):899-901. PubMed ID: 15194309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Frequency and Associated Factors for BK Virus Infection in a Center Performing Mainly Living Kidney Transplantations.
    Alagoz S; Kuskucu M; Gulcicek S; Yalin SF; Oruc M; Midilli K; Yılmaz E; Altiparmak MR; Seyahi N
    Prog Transplant; 2017 Jun; 27(2):152-159. PubMed ID: 28617169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of treatment with 15-deoxyspergualin and BK virus nephropathy in kidney allograft recipients.
    Shi Y; Moriyama T; Namba Y; Yamanaka M; Hanafuse T; Imamura R; Ichimaru N; Oka K; Kyo M; Tian Y; Takahara S; Ichikawa S; Okuyama A
    Clin Transplant; 2007; 21(4):502-9. PubMed ID: 17645710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical Correlations.
    Nickeleit V; Singh HK; Randhawa P; Drachenberg CB; Bhatnagar R; Bracamonte E; Chang A; Chon WJ; Dadhania D; Davis VG; Hopfer H; Mihatsch MJ; Papadimitriou JC; Schaub S; Stokes MB; Tungekar MF; Seshan SV;
    J Am Soc Nephrol; 2018 Feb; 29(2):680-693. PubMed ID: 29279304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyomavirus-associated nephropathy in renal transplantation: critical issues of screening and management.
    Hirsch HH; Drachenberg CB; Steiger J; Ramos E
    Adv Exp Med Biol; 2006; 577():160-73. PubMed ID: 16626034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal transplant patient with polyoma virus bladder infection and subsequent polyoma virus nephropathy.
    Weinreb DB; Desman GT; Burstein DE; Dikman SH; Johnson EM
    Int J Urol; 2006 Apr; 13(4):439-41. PubMed ID: 16734867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
    Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
    Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of patients with rejection post-polyomavirus nephropathy.
    Trofe J; Roy-Chaudhury P; Gordon J; Wadih G; Maru D; Cardi MA; Succop P; Alloway RR; Khalili K; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):942-4. PubMed ID: 15848582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preemptive reduction of immunosuppression upon high urinary polyomavirus loads improves patient survival without affecting kidney graft function.
    Broeders EN; Hamade A; El Mountahi F; Racapé J; Hougardy JM; Le Moine A; Vereerstraeten P
    Transpl Infect Dis; 2016 Dec; 18(6):872-880. PubMed ID: 27615506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy.
    Puliyanda DP; Amet N; Dhawan A; Hilo L; Radha RK; Bunnapradist S; Czer L; Martin P; Jordan S; Toyoda M
    Clin Transplant; 2006; 20(3):289-94. PubMed ID: 16824143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.